What are some of the limitations of topical steroids with respect to management of plaque psoriasis?
Featuring Jennifer Soung, MD | MD |
Director of Clinical Research
Southern California Dermatology
Clinical Faculty
Harbor University of California Los Angeles
Santa Ana, CA
More from this series
Psoriasis
Can you explain the significance of roflumilast’s indication being inclusive of intertriginous areas with plaque psoriasis?
Featuring Jennifer Soung, MD
Psoriasis
What are important considerations when treating plaque psoriasis in sensitive areas such as the face, folds, and genitals?
Featuring Jennifer Soung, MD
Psoriasis
Can topical roflumilast be used in combination with systemic therapies?
Featuring Jennifer Soung, MD
Psoriasis
How would you describe the formulation/vehicle for topical roflumilast?
Featuring Jennifer Soung, MD
Related CME
1 Credit
Click to save this course
Psoriasis
CME
FC24: The Comorbidities of Psoriasis: What Clinicians Need to Know to Optimize Care: An Online Activity
Release Date
December 12, 2024
0.75 Credit
Click to save this course
Psoriasis
CME
FC24: Practical Insights and Pitfalls for Psoriatic Disease in Skin of Color: Early Diagnosis for Effective Treatment: An Online Activity
Release Date
December 12, 2024
0.5 Credit
Click to save this course
Psoriasis
CME
FC24: Palmoplantar Pustulosis: Looking Ahead to New Treatment Options: An Online Activity
Release Date
December 8, 2024
Related Media
Powered by Polaris TM